These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 386054)

  • 1. Protective effect of OK-432 (a streptococcal preparation) on experimental candidiasis.
    Shiraishi A; Mikami Y; Arai T
    Microbiol Immunol; 1979; 23(6):549-54. PubMed ID: 386054
    [No Abstract]   [Full Text] [Related]  

  • 2. Candidosis.
    Shepherd MG; Smith JM; Sullivan PA; Meech RJ; Poulter RT
    N Z Med J; 1983 Aug; 96(737):619-21. PubMed ID: 6346160
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of neutrophil function in host defense against disseminated Candida albicans infection in mice.
    Kullberg BJ; Netea MG; Vonk AG; van der Meer JW
    FEMS Immunol Med Microbiol; 1999 Dec; 26(3-4):299-307. PubMed ID: 10575142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of the sodium salt of N-succinylperimycin and nystatin in experimental candidiasis of white mice.
    Rutecka-Bonin I
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):547-53. PubMed ID: 4952937
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist.
    Cenci E; Mencacci A; Del Sero G; Fé d'Ostiani C; Montagnoli C; Bacci A; Bistoni F; Romani L
    J Chemother; 1998 Apr; 10(2):160-3. PubMed ID: 9603646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the effect of a new polyfungin derivative in chronic infection of albino mice with P-32 labeled Candida albicans].
    Kurnatowska A; Brykalski D; Kowszyk-Gindifer Z; Kwaśniewska J; Rózga A
    Med Dosw Mikrobiol; 1989; 41(1):53-9. PubMed ID: 2668660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in systemic candidosis.
    Winner HI
    Contrib Microbiol Immunol; 1977; 4():64-76. PubMed ID: 342193
    [No Abstract]   [Full Text] [Related]  

  • 8. Rutin has therapeutic effect on septic arthritis caused by Candida albicans.
    Han Y
    Int Immunopharmacol; 2009 Feb; 9(2):207-11. PubMed ID: 19041425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactoferrin peptide increases the survival of Candida albicans-inoculated mice by upregulating neutrophil and macrophage functions, especially in combination with amphotericin B and granulocyte-macrophage colony-stimulating factor.
    Tanida T; Rao F; Hamada T; Ueta E; Osaki T
    Infect Immun; 2001 Jun; 69(6):3883-90. PubMed ID: 11349055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotics produced by Streptomyces olivaceus 142. Antifungal properties of antibiotic WR-142 FPG.
    Wieczorek J; Mordarski M
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):433-9. PubMed ID: 383040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micafungin Enhances the Human Macrophage Response to Candida albicans through β-Glucan Exposure.
    Guirao-Abad JP; Sánchez-Fresneda R; Machado F; Argüelles JC; Martínez-Esparza M
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans.
    Hu Y; Farah CS; Ashman RB
    Immunol Cell Biol; 2006 Oct; 84(5):455-60. PubMed ID: 16869942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human recombinant antibody against Candida.
    Rowlands HE; Morris K; Graham C
    Pediatr Infect Dis J; 2006 Oct; 25(10):959-60. PubMed ID: 17006302
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of Post-Vaccination Phagocytic Activation Using Candida albicans Killing Assays.
    Li W; Hu Y
    Methods Mol Biol; 2017; 1625():313-326. PubMed ID: 28584999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytic killing of Candida albicans by different murine effector cells.
    Baccarini M; Blasi E; Puccetti P; Bistoni F
    Sabouraudia; 1983 Dec; 21(4):271-86. PubMed ID: 6362037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
    Onyewu C; Afshari NA; Heitman J
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3963-5. PubMed ID: 16923949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
    Khan MA; Khan A; Owais M
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):63-9. PubMed ID: 16420598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lysosomotropic form of amphotericin B on functional state of phagocytes in experimental candidiasis.
    Kurilin VV; Saperova MA; Efanov EA; Tsyrendorzhiev DD; Shkurupiy VA
    Bull Exp Biol Med; 2008 Dec; 146(6):698-700. PubMed ID: 19513358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
    Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
    J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse intravenous challenge models and applications.
    MacCallum DM
    Methods Mol Biol; 2012; 845():499-509. PubMed ID: 22328398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.